Sharing our perspective

Sharing perspectives leads to greater understanding and fuels innovation. The ​Optum Insights ​blog is where we share our perspective and challenge preconceptions to clear a new path forward.


  • Michigan Legislator Introduces Bill to Create Auto No-Fault Options

    by
    • Optum Workers' Comp
    | May 01, 2017
    Tag Icon
    Fraud
    Michigan Representative Jason Sheppard has introduced HB 4488 in the Michigan House of Representatives and the legislation has been referred to the House Insurance Committee for further consideration. Currently, under Michigan Law, personal protection insurance benefits have no maximum limit.


  • RoxyBond™ (immediate-release oxycodone hydrochloride, abuse-deterrent)

    by
    • Optum Workers' Comp
    | Apr 28, 2017
    Tag Icon
    Opioids, Medication Plans, Pain Management, Abuse Deterrent, FDA
    The U.S. Food and Drug Administration (FDA) approved a new abuse-deterrent, immediate-release opioid analgesic, RoxyBond™, to manage pain severe enough to require an opioid analgesic and for which alternative treatment options are inadequate. RoxyBond contains oxycodone hydrochloride and is manufactured by Inspirion Delivery Sciences LLC.


  • National Prescription Drug Take-Back Day Slated for April 29

    by
    • Optum Workers' Comp
    | Apr 27, 2017
    Tag Icon
    Opioids, Medication Safety, DEA
    Saturday, April 29 is National Prescription Drug Take-Back Day sponsored by the U.S. Drug Enforcement Administration (DEA). The purpose of National Prescription Drug Take-Back Day is to provide a safe, convenient, and responsible way to dispose of prescription medications that are unwanted, unused, or expired, while also educating the public on the potential for the abuse of medications.


  • Drug Recall: Single lot of Phenobarbital recalled

    by
    • Optum Workers' Comp
    | Apr 21, 2017
    Tag Icon
    Medication Recall, FDA
    The U.S. Food and Drug Administration (FDA) announced C.O. Truxton, Inc. voluntarily recalled one lot of Phenobarbital 15 mg tablets after the manufacturer received a complaint that a bottle was mislabeled. According to the manufacturer, a bottle labeled as 15 mg contained 30 mg tablets.






Subscribe

Stay informed by signing up to receive newsletters, alerts, insights and videos.
You can customize your content preferences after you subscribe.